Copyright 2024 The Associated Press. All Rights Reserved. Mikayla Brown and her husband, Tyler, visit the grave of their son, Elijah, who died of a fentanyl overdose ...

Ozempic maker Novo Nordisk says its highly anticipated experimental weight-loss pill Amycretin was safe and tolerable for patients in an early-stage trial, with mild-to-moderate side effects.

There were only two cases among 2,180 patients – effectively reducing the risk of HIV infection by 96% and proving 89% more effective than Truvada, a pill taken once a day. The trial was ...

The pill is made by Novo Nordisk, the same company that makes Ozempic. The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that ...

The maker of injectable weight loss drugs including Ozempic and Wegovy is touting the results of an early-stage trial that delivered weight loss success by taking a daily pill. Novo Nordisk released ...

Copyright 2024 The Associated Press. All Rights Reserved. Cancer patient Steven Manetta sits for a portrait Thursday, Aug. 29, 2024, in his Lemont, Ill., home ...

In conversation with experts, we’ll break down what you need to know about the most commonly prescribed type of contraception in the United States: the pill. “The most common and most familiar ...

Since the days of Abraham — who, according to Genesis, rescued his nephew Lot after he’d been seized by an invading army — Jewish tradition has placed supreme value on the redemption of ...

GMRx2, a new combination pill for hypertension, was found to be more effective than standard care in reducing blood pressure. The pill showed impressive results, achieving blood pressure control in ...

The latest Stop Stockouts and Ritshidze report shows that planning problems, small budgets and poor record systems are part of the reason. Could getting birth control pills or emergency contraception ...

Sanofi said an oral treatment for multiple sclerosis, tolebrutinib, met its key goal in a Phase 3 study, potentially clearing the way for regulatory approval, although in two other studies ...